Japanese jornal of Head and Neck Cancer
Online ISSN : 1883-9878
Print ISSN : 0911-4335
ISSN-L : 0911-4335
EVALUATION OF THE CHEMOSENSITIVITY OF HEAD AND NECK CANCER BASED ON DIVERSE FUNCTION OF MUTATED-p53
Yasuhiro SHINAGAWAHitoshi KAWAMATAFumie OMOTEHARAKoh-ichi NAKASHIROYutaka IMAITakashi FUJIBAYASHITakahiro FUJIMORI
Author information
JOURNAL FREE ACCESS

2002 Volume 28 Issue 1 Pages 264-268

Details
Abstract
The chemosensitivity of head and neck cancer was evaluated based on the diverse function of mutated-p53. Two human head and neck cancer cell lines harboring mutated p53 gene, HSG (Asn30Ser) and TYS (Asp281His) were used. We transfected the cells with luciferase reporter plasmids containing promoter sequence of p53 target genes (p21waf1 BAX, MDM2). After treating the cells with chemotherapeutic agents, adriamycin, 5-fluorouracil and cisplatin, luciferase activity was measured. In HSG cells, none of the target gene promoters was activated by treatment with the chemotherapeutic agents. However, in TYS cells, p21waf1 promoter was markedly activated by the chemotherapeutic agents. In both cells, Bax promoter was not activated irrespective of treatment with the chemotherapeutic agents. Under DNA damaging stress, TYS-derived p53 may arrest the cell cycle by induction of p21waf1, but did not induce apoptosis. Analysis for diverse function of mutated-p53 may help to determine the therapeutic strategy, especially chemotherapeutic strategy in the individual patient with head and neck cancer.
Content from these authors
© Japan Society for Head and Neck Cancer
Previous article Next article
feedback
Top